Dianthus Therapeutics (DNTH) Stock Chart & Stock Price History $21.97 +0.27 (+1.23%) As of 10:20 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dianthus Therapeutics Stock Price Performance 5 Day Performance+1.37%1 Month Performance+22.99%3 Month Performance-0.83%6 Month Performance-21.58%Year-To-Date Performance+0.76%1 Year Performance-8.51% Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DNTH Stock Chart for Friday, May, 2, 2025 DNTH Chart by TradingView Dianthus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$21.85$21.70-0.69%$22.05$21.00280,459 shs$697.13 million04/30/2025$21.75$21.85+0.46%$22.03$20.81262,781 shs$701.95 million04/29/2025$21.45$21.75+1.40%$22.30$20.76198,981 shs$698.74 million04/28/2025$21.67$21.45-1.02%$22.20$20.77347,325 shs$689.10 million04/25/2025$21.23$21.67+2.07%$21.72$20.64198,482 shs$696.17 million04/24/2025$21.56$21.23-1.53%$22.04$20.86335,240 shs$682.04 million04/23/2025$21.87$21.56-1.42%$23.69$21.23247,843 shs$692.64 million04/22/2025$20.45$21.87+6.94%$21.96$20.37282,090 shs$702.60 million04/21/2025$19.50$20.45+4.87%$21.40$18.65429,594 shs$656.98 million04/18/2025$19.50$19.50$19.70$18.87180,937 shs$626.46 million Get the Latest News and Ratings for DNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$18.98$19.50+2.74%$19.70$18.87180,937 shs$626.44 million04/16/2025$19.21$18.98-1.20%$19.53$18.37228,998 shs$609.73 million04/15/2025$18.71$19.21+2.67%$19.76$18.48314,429 shs$617.12 million04/14/2025$17.61$18.71+6.25%$19.11$17.16241,079 shs$601.06 million04/11/2025$15.60$17.61+12.88%$17.64$15.25304,304 shs$565.72 million04/10/2025$16.33$15.60-4.47%$17.00$14.51876,597 shs$501.15 million04/09/2025$14.86$16.33+9.89%$16.37$13.37961,742 shs$524.60 million04/09/2025$14.86$16.33+9.89%$16.37$13.37961,742 shs$524.60 million04/08/2025$15.61$14.86-4.80%$16.66$14.60902,525 shs$477.38 million04/08/2025$15.61$14.86-4.80%$16.66$14.60902,525 shs$477.38 million04/07/2025$16.12$15.61-3.16%$16.69$14.93352,415 shs$501.47 million04/04/2025$16.97$16.12-5.01%$18.13$14.78398,315 shs$517.86 million04/03/2025$17.86$16.97-4.98%$17.42$15.89483,270 shs$545.16 million04/02/2025$16.83$17.86+6.12%$18.64$16.53949,121 shs$573.75 million04/01/2025$18.14$16.83-7.22%$17.98$16.44285,845 shs$540.66 million Related Companies Protagonist Therapeutics Stock Price Chart HUTCHMED Stock Price Chart Immunovant Stock Price Chart Apellis Pharmaceuticals Stock Price Chart MoonLake Immunotherapeutics Stock Price Chart ACADIA Pharmaceuticals Stock Price Chart Alvotech Stock Price Chart Twist Bioscience Stock Price Chart Amneal Pharmaceuticals Stock Price Chart Denali Therapeutics Stock Price Chart Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DNTH) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
